U.S. FDA meeting on Covid-19 vaccines to discuss criteria for emergency nod
Ireland Imposes New Fines For Violating Europe's Most Restrictive Lockdown: Live Updates
Moderna CEO expects Covid-19 vaccine interim results in November – WSJ
India Reports Fewest COVID-19 Cases In 3 Months; Argentina 5th Country To Top 5 Million Cases: Live Updates
Macro Briefing: 20 October 2020
Kamada To Supply Plasma-Based Covid-19 Therapy To Israel; Shares Surge 6%
Pfizer: The Pace of COVID-19 Vaccine Development Is Remarkable, Says Analyst
AstraZeneca Gets EU Recommendations For Heart Failure, Lung Treatments
Goldman Sachs: 2 Stocks That Could Climb Over 90%
Fluidigm Soars 16% As Covid-19 Saliva Test Selected In US; Analyst Sees 78% Upside
Eli Lilly To Snap Up Disarm In $135M Deal; Street Stays Bullish
Halted Trials Raise New Safety Questions About 'Rushed' COVID-19 Vaccines
Gilead Disputes WHO Data Confirming COVID-19 Drug Remdesivir Is A "Flop"
Canaccord Predicts Over 100% Rally for These 3 “Strong Buy” Stocks
FDA officials, experts discuss impact of Covid-19 on cell and gene therapies
After years of shortages, Merck announces plans for a new factory for an old lifesaving drug
NIH begins large clinical trial to test immune modulators for treatment of COVID-19
Pfizer Plans To Apply For FDA's Emergency-Use Approval During Third Week Of November, CEO Says
COVID-19 tests prop up Roche as US biosimilars bite in Q3
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
Repurposing drugs for a pan-coronavirus treatment
BioNTech: COVID-19 Vaccine Submissions Initiated, But This Analyst Still Says Hold Off
Regeneron Scores FDA Nod For Ebola Treatment
Spain First EU Member To Top 900k COVID-19 Cases; France Revives 'Health Emergency' Order, Imposes Curfews: Live Update
France Imposes COVID-19 'Health Emergency'; Macron Expected To Announce Curfew: Live Update
Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels
UK's Johnson Mulls "Circuit-Breaker" Lockdown, France To Adopt Hot-Spot Curfews As European Outbreaks Worsen: Live Updates
Bill Gates Warns "World Won't Return To Normal" Until "Second Generation" Of COVID-19 Super-Vaccines Arrives
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDA
Facebook Bans Ads Questioning Safety Of COVID-19 Vaccines